Peroxisome proliferator-activated receptor-γ is deficient in alveolar macrophages from patients with alveolar proteinosis

被引:104
作者
Bonfield, TL
Farver, CF
Barna, BP
Malur, A
Abraham, S
Raychaudhuri, B
Kavuru, MS
Thomassen, MJ
机构
[1] Cleveland Clin Fdn, Dept Pulm & Crit Care Med, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Pathol Anat, Cleveland, OH 44195 USA
[3] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA
关键词
D O I
10.1165/rcmb.2003-0148OC
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a ligand-activated, nuclear transcription factor that regulates genes involved in lipid and glucose metabolism, inflammation, and other pathways. The hematopoietic growth factor, granulocyte macrophage colony-stimulating factor (GM-CSF), is essential for lung homeostasis and is thought to regulate surfactant clearance, but mechanisms involved are unknown. GMCSF is reported to stimulate PPAR-gamma, but the activation status of PPAR-gamma in human alveolar macrophages has not been defined. In pulmonary alveolar proteinosis (PAP), a rare interstitial lung disease, surfactant accumulates in alveolar airspaces, resident macrophages become engorged with lipoproteinaceous material, and GM-CSF deficiency is strongly implicated in pathogenesis. Here we show that PPAR-gamma mRNA and protein are highly expressed in alveolar macrophages of healthy control subjects but severely deficient in PAP in a cell-specific manner. Further, we show that the PPAR-gamma-regulated lipid scavenger receptor, CD36, is also deficient in PAP. PPAR-gamma and CD36 deficiency are not intrinsic to PAP alveolar macrophages, but can be upregulated by GM-CSF therapy. Moreover, GM-CSF treatment of patients with PAP fully restores PPAR-gamma to healthy control levels. Based upon these novel findings, we hypothesize that GM-CSF regulates lung homeostasis via PPAR-gamma-dependent pathways.
引用
收藏
页码:677 / 682
页数:6
相关论文
共 42 条
[1]   The mechanisms of action of PPARs [J].
Berger, J ;
Moller, DE .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :409-435
[2]   Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis [J].
Bonfield, TL ;
Kavuru, MS ;
Thomassen, MJ .
CLINICAL IMMUNOLOGY, 2002, 105 (03) :342-350
[3]   Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis [J].
Bonfield, TL ;
Russell, D ;
Burgess, S ;
Malur, A ;
Kavuru, MS ;
Thomassen, MJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 27 (04) :481-486
[4]   NORMAL BRONCHIAL EPITHELIAL-CELLS CONSTITUTIVELY PRODUCE THE ANTIINFLAMMATORY CYTOKINE INTERLEUKIN-10, WHICH IS DOWN-REGULATED IN CYSTIC-FIBROSIS [J].
BONFIELD, TL ;
KONSTAN, MW ;
BURFEIND, P ;
PANUSKA, JR ;
HILLIARD, JB ;
BERGER, M .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 13 (03) :257-261
[5]   Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis [J].
Carraway, MS ;
Ghio, AJ ;
Carter, JD ;
Piantadosi, CA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (04) :1294-1299
[6]   Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages [J].
Chinetti, G ;
Griglio, S ;
Antonucci, M ;
Torra, IP ;
Delerive, P ;
Majd, Z ;
Fruchart, JC ;
Chapman, J ;
Najib, J ;
Staels, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) :25573-25580
[7]   PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway [J].
Chinetti, G ;
Lestavel, S ;
Bocher, V ;
Remaley, AT ;
Neve, B ;
Torra, IP ;
Teissier, E ;
Minnich, A ;
Jaye, M ;
Duverger, N ;
Brewer, HB ;
Fruchart, JC ;
Clavey, V ;
Staels, B .
NATURE MEDICINE, 2001, 7 (01) :53-58
[8]  
Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388
[9]   Emerging roles of PPARs in inflammation and immunity [J].
Daynes, RA ;
Jones, DC .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (10) :748-759
[10]  
Dempke W, 2000, ANTICANCER RES, V20, P5155